Fulcrum Therapeutics Inc (NAS:FULC) Stock News, Headlines & Updates
Fulcrum Therapeutics Inc Stock News from GuruFocus
- 1
Jun 12, 2024
Fulcrum Therapeutics to Present at the 31st Annual FSHD Society International Research Congress
Marketwired • 7:00am
Jun 06, 2024
Fulcrum Therapeutics to Participate in the Goldman Sachs' 45th Annual Global Healthcare Conference
Marketwired • 7:00am
May 14, 2024
Fulcrum Therapeutics Inc (FULC) Q1 2024 Earnings Call Transcript Highlights: Strategic Alliances and Financial Trajectory
GuruFocus Research • 1:01am
Q1 2024 Fulcrum Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 11:02pm
May 13, 2024
Fulcrum Therapeutics Q1 2024 Earnings: Misses Analyst Net Income Projections Amid Strategic Collaborations
GuruFocus Research • 6:32am
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024
Marketwired • 6:00am
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
Marketwired • 5:00am
May 09, 2024
Fulcrum Therapeutics to Participate in Upcoming May Conferences
Marketwired • 7:00am
May 08, 2024
Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology
Marketwired • 7:00am
May 06, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news